Evaluating the advantages and potential drawbacks of shielding as a method for safe RL. Bettina Könighofer is an assistant professor at Graz University of Technology, Graz, Austria. Roderick Bloem ...
The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback